Development of a predictive in vitro dissolution for clarithromycin granular suspension based on in vitro-in vivo correlations.
The objective of this study was to evaluate the in vitro behavior of different clarithromycin granular suspensions based on a developed in vitro-in vivo correlation model, using one reference and two test formulations. In vitro release rate data were obtained for each product using the USP apparatus II, operated at 50 rpm under different pH conditions. The dissolution efficiency was used to analyze the dissolution data. In vivo study was performed on six healthy male volunteers under fasting condition. Correlation was made between in vitro release and in vivo absorption. A linear model was developed using percent absorbed data versus percent dissolved data from the three products. Dissolution condition of 0.1N HCl for 1 h and then phosphate buffer at pH 6.8 was found to be the most discriminating dissolution method. Rate of absorption for the reference as estimated by Wagner-Nelson deconvolution was correlated with in vitro release with a correlation coefficient of 0.99. The in vivo results for the two test products were compared to the predicted values using the reference model with a correlation coefficient of 0.94. Furthermore, multiple level C correlations were obtained for some pharmacokinetic parameters with the corresponding in vitro kinetic parameters with correlation coefficients exceeding 0.90. Moreover, the interpretation of the in vitro and in vivo data with reference to formulations was discussed.
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Jordan, Amman, Jordan. b.khalidi@ju.edu.jo
Bashar A
BA
Alkhalidi
Mutasim
M
Al-Ghazawi
Hatim S
HS
AlKhatib
AlSayed
A
Sallam
D000293:Adolescent; D000328:Adult; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D017291:Clarithromycin / Q000737:chemistry* / Q000493:pharmacokinetics*; D018592:Cross-Over Studies; D005544:Forecasting; D006801:Humans; D008297:Male; D012995:Solubility; D013535:Suspensions; D055815:Young Adult
D013535:Suspensions; D017291:Clarithromycin